AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.280
+0.010 (0.79%)
At close: Sep 12, 2025, 4:00 PM EDT
1.250
-0.030 (-2.34%)
After-hours: Sep 12, 2025, 4:20 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $34.98 million as of September 12, 2025. Its market cap has increased by 0.18% in one year.
Market Cap
34.98M
Enterprise Value
-27.94M
1-Year Change
0.18%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $34.98M, a decrease of -87.56%. That is a compound annual growth rate of -45.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 34.98M | -15.17% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |